Mahesh Vijaykant Nabar
Directeur Financier/CFO chez Unidrug Innovative Pharma Technologies Ltd.
Profil
Mahesh Vijaykant Nabar is currently the Chief Financial Officer at Unidrug Innovative Pharma Technologies Ltd.
He completed his undergraduate degree from the University of Rajasthan and his graduate degree from Devi Ahilya University.
Postes actifs de Mahesh Vijaykant Nabar
| Sociétés | Poste | Début |
|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Directeur Financier/CFO | 01/08/2018 |
Formation de Mahesh Vijaykant Nabar
| University of Rajasthan | Undergraduate Degree |
| Devi Ahilya University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
